Atara Biotherapeutics Inc
NASDAQ:ATRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
|
Sembcorp Industries Ltd
SGX:U96
|
SG |
|
Phoenix Mecano AG
SIX:PM
|
CH |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
Tsakos Energy Navigation Ltd
NYSE:TEN
|
GR |
|
C
|
COMPUTERSHARE LIMITED
F:QCH
|
AU |
|
BYD Co Ltd
OTC:BYDDF
|
CN |
|
R
|
Renault SA
F:RNL1
|
FR |
|
Littelfuse Inc
NASDAQ:LFUS
|
US |
|
QMMM Holdings Ltd
NASDAQ:QMMM
|
HK |
|
P
|
PIE Industrial Bhd
KLSE:PIE
|
MY |
|
Samsung Electronics Co Ltd
F:SSUN
|
KR |
Wall St Price Targets
ATRA Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for ATRA is 11.9 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATRA's stock price target?
Price Target
11.9
USD
According to Wall Street analysts, the average 1-year price target for ATRA is 11.9 USD with a low forecast of 4.04 USD and a high forecast of 18.9 USD.
What is the Revenue forecast for Atara Biotherapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Revenue over the next 8 years is -5%.
What is the Operating Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 5 years is 2%.
What is the Net Income forecast for Atara Biotherapeutics Inc?
Projected CAGR
-2%
The compound annual growth rate for Net Income over the next 8 years is -2%.
